Czechia· CZ-0238239
EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA
A emtricitabine, tenofovir disoproxil and efavirenz product, registered in Czechia by Zentiva, k.s., Praha. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Manufacturer
- Zentiva, k.s., Praha
- Country
- Czechia (CZ)
- ATC code
- J05AR06
- ATC class
- Emtricitabine, tenofovir disoproxil and efavirenz
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- July 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under J05AR06
Emtricitabine, tenofovir disoproxil and efavirenz, as other registers publish it.
- CanadaAPO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRAPOTEX INC
- FinlandAtriplaParanova Oy
- FinlandAtriplaAbacus Medicine A/S
- FinlandAtriplaGilead Sciences Ireland UC
- FinlandAtriplaOrifarm Oy
- BelgiumAtripla 600 mg - 200 mg - 245 mgGilead Sciences Ireland UC
- United KingdomAtripla 600mg/200mg/245mg tabletsGilead Sciences Ltd
- CanadaAURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRAURO PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba837d88-6e99-4518-9ed7-0b9953d1b77f GET /v1/drugs/ba837d88-6e99-4518-9ed7-0b9953d1b77f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "600MG/200MG/245MG",
"pack_size": "90(3X30)",
"substance": "15485,15579,20643",
"cz_kod_sukl": "0238239",
"product_type": "CH",
"registration_state": "R",
"registration_number": "EU/1/17/1210/002"
}See everything about emtricitabine, tenofovir disoproxil and efavirenz.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.